This study, focusing on Iran’s experience during the COVID-19 pandemic, examines the role of emerging technologies in enhancing health diplomacy and crisis policy-making. The main problem addressed is that despite Iran’s indigenous capacity in drug and vaccine production and its extensive primary health care network, the country failed to secure an effective position in global health governance and international interactions. The central research question asks how emerging technologies—such as artificial intelligence, big data, and telemedicine—can be employed to strengthen health diplomacy and crisis management in Iran. The purpose of the study is to analyze the strengths and weaknesses of Iran’s health policies during the COVID-19 crisis and to provide strategies for linking technological innovation with international health policy-making. The main hypothesis is that the systematic use of emerging technologies can, while enhancing domestic responsiveness, foster international trust and strengthen Iran’s position in global health governance. The methodology is descriptive-analytical, relying on library and documentary sources. The findings reveal that institutional incoherence, the dominance of security-oriented approaches, and sanctions impeded the full utilization of technological capacities. Nevertheless, experiences such as domestic vaccine production, the use of digital platforms to monitor patients, and the involvement of civil society highlight significant potential which, if supported by proper policy-making, can contribute to strengthening Iran’s health diplomacy.
Introduction
The COVID-19 pandemic represented a turning point in global health governance, revealing both the vulnerabilities and capacities of national health systems. Like many other countries, Iran faced a multifaceted and unprecedented challenge that intertwined health, politics, technology, and international relations. The first confirmed cases were detected in Qom and rapidly spread nationwide. Iran’s health system, despite its historical achievements in vaccination campaigns and the wide-reaching primary health care network, encountered severe limitations due to international sanctions, shortages of medical equipment, institutional fragmentation, and the dominance of securitized approaches over health-driven decisions. Under these circumstances, the role of emerging technologies and health diplomacy became even more vital. The central research question of this study is how emerging technologies—such as artificial intelligence (AI), big data analytics, and telemedicine—can strengthen health diplomacy and crisis policy-making in Iran. The significance of this question lies in the paradox that although Iran demonstrated indigenous capacity in drug and vaccine production, it was unable to secure an influential role in global health governance. The main objective of the study is to analyze Iran’s COVID-19 experience, identify strengths and weaknesses, and propose pathways to link technological innovation with international health policy-making.
Main Body
Emerging technologies during COVID-19 proved to be indispensable tools for crisis management. Countries that effectively utilized big data analytics for tracking cases, predicting epidemiological patterns, and allocating resources succeeded in slowing down the spread of the virus. Iran, to some extent, employed digital platforms for patient registration and monitoring. However, institutional fragmentation, insufficient interoperability, and underdeveloped infrastructure restricted the comprehensive use of such tools. Regarding artificial intelligence, Iranian universities and research centers had technical capacities for modeling and prediction, but weak linkages between academia and policy-making prevented systemic application of these capabilities. In the domain of telemedicine, although some initiatives were introduced to provide remote consultation and treatment, the lack of legal frameworks and standardized protocols limited their effectiveness.
From the perspective of health diplomacy, the pandemic created a window of opportunity for states to enhance their international standing through technological collaboration. Iran made strides in vaccine development, with projects like “COVIran Barekat” demonstrating scientific potential. Yet, insufficient international trust in efficacy, coupled with sanctions that constrained access to raw materials and distribution channels, hindered the use of these achievements as diplomatic leverage. Moreover, the dominance of a security-oriented discourse in foreign policy prevented health from being institutionalized as a strategic pillar of diplomacy. The Iranian experience thus illustrates that without integrating technological innovation with proactive diplomacy, national capacities remain underutilized in the global arena.
Methodology
This research employs a descriptive–analytical approach. Data were collected through a combination of library-based resources, international institutional reports (e.g., WHO), and peer-reviewed academic literature. The study applies a qualitative comparative lens to situate Iran’s COVID-19 experience within broader global practices, highlighting both parallels and divergences. This methodological design enables the identification of institutional and policy gaps as well as potential strategies for improvement.
Findings
The findings of the study reveal a dual reality. On the one hand, Iran demonstrated significant strengths: indigenous production of drugs and vaccines, partial adoption of digital surveillance systems for patient tracking, and the mobilization of civil society and religious organizations to provide community support. These dimensions indicate the presence of latent institutional and social capital that can be activated during crises. On the other hand, critical limitations were observed: poor institutional coordination, the securitization of decision-making processes, the absence of clear legal frameworks for telemedicine, and the economic restrictions of international sanctions. The study also underscores the missed opportunity in health diplomacy. While countries such as South Korea and China leveraged big data and AI not only to improve domestic management but also to project an image of technological competence internationally, Iran’s comparable efforts lacked diplomatic visibility. Consequently, Iran’s scientific and technological contributions were not translated into global trust or influence. These findings highlight that emerging technologies can serve a dual function: domestically as managerial instruments, and internationally as diplomatic assets.
Conclusion
The overall conclusion is that systematic adoption of emerging technologies can simultaneously enhance domestic crisis response and elevate international credibility. For Iran, the COVID-19 pandemic showed that while scientific and technological capacities exist, without institutional reform, legal development, and an active strategy of health diplomacy, such capacities cannot produce sustainable outcomes. Future health policy-making in Iran must therefore prioritize the integration of technological innovation with diplomacy. This dual focus will not only improve national resilience against future crises but also strengthen Iran’s engagement in regional and global health governance. In doing so, Iran can transition from reactive management to proactive leadership in health diplomacy.